VTIAF

Founded in 1997 and headquartered in Leipzig, Germany, VITA 34 AG specializes in collecting, processing, and banking stem cells sourced from umbilical cord blood and tissue. The company's operations extend across Germany, Spain, and various international markets. Beyond these core activities, VITA 34 AG actively develops cell therapeutic procedures, advances cell and gene therapies, and engages with CAR-T technology, while also offering cryopreservation for endogenous immune cells. Furthermore, it manufactures advanced therapy medicinal products (ATMPs) using mesenchymal stem cells for experimental application by specialized medical institutions. The firm also preserves stem cells obtained from perinatal tissue and adult body fat, and provides contract manufacturing services for pharmaceutical intermediates.